Keywords: dyax, expands, ab, deal, biogen, biotherapeutics, firm

Dyax expands Ab deal with Biogen

Article | 16 February 2009

Print This

Biotherapeutics firm Dyax says it has expanded its antibody funded research and library license agreement with fellow USA-based Biogen Idec ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in